Semaglutide improves health-related quality of life vs placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6)
| Image |  |
|---|---|
| Description | scientific article published on 30 March 2020 |
| Author/s |
author: Mark Warren Stephen Bain Tina Vilsbøll |
| Publication date | March 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |